First data on Pfizer-BioNTech's Omicron BA.4/5 combination v

First data on Pfizer-BioNTech's Omicron BA.4/5 combination vaccine

In a recent study posted to the bioRxiv* preprint server, researchers from Germany and the United States analyzed the association between exposure to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron BA.4/BA.5 spike glycoprotein and pan-Omicron neutralization.

Related Keywords

Wuhan , Hubei , China , Germany , United States , , Coronavirus Disease Covid 19 , Micron , Vaccine , Ntibody , Coronavirus , Covid 19 , Lycoprotein , Homologous , Immunity , Immunization , Pandemic , Pseudovirus , Espiratory , Ibonucleic Acid , Cars , Ars Cov 2 , Evere Acute Respiratory , Evere Acute Respiratory Syndrome , Yndrome ,

© 2025 Vimarsana